Osteonecrosis of the jaw in patient with denosumab therapy

Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical and experimental medicine 2014-01, Vol.7 (10), p.3707-3709
Main Authors: Olate, Sergio, Uribe, Francisca, Martinez, Felipe, Almeida, Andrés, Unibazo, Alejandro
Format: Article
Language:English
Subjects:
Original
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 3709
container_issue 10
container_start_page 3707
container_title International journal of clinical and experimental medicine
container_volume 7
creator Olate, Sergio
Uribe, Francisca
Martinez, Felipe
Almeida, Andrés
Unibazo, Alejandro
description Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238486</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1637551901</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-591976cf8e026fe91216ad8b557bbade2c5c1436a0f41485fe42ccdd8999eeb53</originalsourceid><addsrcrecordid>eNpVkF1LwzAYhYMobk7_guTSm0Hz2cYLQYZfMNiNXoc0fWsz2qY2qWP_3ohT5tV74Bye83JO0Jwoni2FysjpkZ6hixC2WSYJZeoczajgyaNkjm43IYLvwY4-uIB9jWMDeGt22PV4MNFBH_HOxQZX0Pswdab8Toxm2F-is9q0Aa4Od4HeHh9eV8_L9ebpZXW_Xg5Uypj6icqlrQvIqKxBEUqkqYpSiLwsTQXUCks4kyarOeGFqIFTa6uqUEoBlIIt0N0Pd5jKDiqbPhpNq4fRdWbca2-c_u_0rtHv_lNzygpeyAS4OQBG_zFBiLpzwULbmh78FDSRLBeCpJ1S9Pq466_kdzD2BQcwaXs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1637551901</pqid></control><display><type>article</type><title>Osteonecrosis of the jaw in patient with denosumab therapy</title><source>Open Access: PubMed Central</source><creator>Olate, Sergio ; Uribe, Francisca ; Martinez, Felipe ; Almeida, Andrés ; Unibazo, Alejandro</creator><creatorcontrib>Olate, Sergio ; Uribe, Francisca ; Martinez, Felipe ; Almeida, Andrés ; Unibazo, Alejandro</creatorcontrib><description>Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed.</description><identifier>ISSN: 1940-5901</identifier><identifier>EISSN: 1940-5901</identifier><identifier>PMID: 25419421</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Original</subject><ispartof>International journal of clinical and experimental medicine, 2014-01, Vol.7 (10), p.3707-3709</ispartof><rights>IJCEM Copyright © 2014 2014</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238486/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238486/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53782,53784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25419421$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olate, Sergio</creatorcontrib><creatorcontrib>Uribe, Francisca</creatorcontrib><creatorcontrib>Martinez, Felipe</creatorcontrib><creatorcontrib>Almeida, Andrés</creatorcontrib><creatorcontrib>Unibazo, Alejandro</creatorcontrib><title>Osteonecrosis of the jaw in patient with denosumab therapy</title><title>International journal of clinical and experimental medicine</title><addtitle>Int J Clin Exp Med</addtitle><description>Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed.</description><subject>Original</subject><issn>1940-5901</issn><issn>1940-5901</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkF1LwzAYhYMobk7_guTSm0Hz2cYLQYZfMNiNXoc0fWsz2qY2qWP_3ohT5tV74Bye83JO0Jwoni2FysjpkZ6hixC2WSYJZeoczajgyaNkjm43IYLvwY4-uIB9jWMDeGt22PV4MNFBH_HOxQZX0Pswdab8Toxm2F-is9q0Aa4Od4HeHh9eV8_L9ebpZXW_Xg5Uypj6icqlrQvIqKxBEUqkqYpSiLwsTQXUCks4kyarOeGFqIFTa6uqUEoBlIIt0N0Pd5jKDiqbPhpNq4fRdWbca2-c_u_0rtHv_lNzygpeyAS4OQBG_zFBiLpzwULbmh78FDSRLBeCpJ1S9Pq466_kdzD2BQcwaXs</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Olate, Sergio</creator><creator>Uribe, Francisca</creator><creator>Martinez, Felipe</creator><creator>Almeida, Andrés</creator><creator>Unibazo, Alejandro</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140101</creationdate><title>Osteonecrosis of the jaw in patient with denosumab therapy</title><author>Olate, Sergio ; Uribe, Francisca ; Martinez, Felipe ; Almeida, Andrés ; Unibazo, Alejandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-591976cf8e026fe91216ad8b557bbade2c5c1436a0f41485fe42ccdd8999eeb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Olate, Sergio</creatorcontrib><creatorcontrib>Uribe, Francisca</creatorcontrib><creatorcontrib>Martinez, Felipe</creatorcontrib><creatorcontrib>Almeida, Andrés</creatorcontrib><creatorcontrib>Unibazo, Alejandro</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical and experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olate, Sergio</au><au>Uribe, Francisca</au><au>Martinez, Felipe</au><au>Almeida, Andrés</au><au>Unibazo, Alejandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteonecrosis of the jaw in patient with denosumab therapy</atitle><jtitle>International journal of clinical and experimental medicine</jtitle><addtitle>Int J Clin Exp Med</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>7</volume><issue>10</issue><spage>3707</spage><epage>3709</epage><pages>3707-3709</pages><issn>1940-5901</issn><eissn>1940-5901</eissn><abstract>Osteonecrosis (ON) of the jaw has previously been linked to the use of biphosphonates; however, new drugs, also shown similar conditions. This article presents a female patient with mandibular ON related to the use of denosumab. The 55-year-old presented with bone exposure with 8 months of evolution after a dental extraction. The patient began subcutaneous injections of 60 mg denosumab four months prior to the extraction and the lesion remained after the procedure. The patient, with 14 months of follow-up, show mandible ON with no favorable evolution. The clinical condition is presented and the literature of ON associated with denosumab is discussed.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>25419421</pmid><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1940-5901
ispartof International journal of clinical and experimental medicine, 2014-01, Vol.7 (10), p.3707-3709
issn 1940-5901
1940-5901
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4238486
source Open Access: PubMed Central
subjects Original
title Osteonecrosis of the jaw in patient with denosumab therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T23%3A17%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteonecrosis%20of%20the%20jaw%20in%20patient%20with%20denosumab%20therapy&rft.jtitle=International%20journal%20of%20clinical%20and%20experimental%20medicine&rft.au=Olate,%20Sergio&rft.date=2014-01-01&rft.volume=7&rft.issue=10&rft.spage=3707&rft.epage=3709&rft.pages=3707-3709&rft.issn=1940-5901&rft.eissn=1940-5901&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1637551901%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p266t-591976cf8e026fe91216ad8b557bbade2c5c1436a0f41485fe42ccdd8999eeb53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1637551901&rft_id=info:pmid/25419421&rfr_iscdi=true